We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $60.8B
1-Year Est. Return 42.06%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
AUM
$49.3B
AUM Growth
+$3.1B
Cap. Flow
-$516M
Cap. Flow %
-1.05%
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$78.5M
2
NVDA icon
NVIDIA
NVDA
+$75.6M
3
LLY icon
Eli Lilly
LLY
+$70.2M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$58.7M
5
META icon
Meta Platforms (Facebook)
META
+$55.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$107M
2
PFE icon
Pfizer
PFE
+$70M
3
JNJ icon
Johnson & Johnson
JNJ
+$68M
4
DHR icon
Danaher
DHR
+$56.4M
5
WMT icon
Walmart Inc
WMT
+$54.2M

Sector Composition

Rank Sector Weight
1 Technology 25.47%
2 Healthcare 17.5%
3 Financials 11.6%
4 Consumer Discretionary 9.63%
5 Industrials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSII
1701
DELISTED
Heidrick & Struggles
HSII
$337K ﹤0.01%
12,750
INGN icon
1702
Inogen
INGN
$144M
$335K ﹤0.01%
28,965
+8,050
+38% +$94.9K
EGBN icon
1703
Eagle Bancorp
EGBN
$859M
$331K ﹤0.01%
15,640
SPWR
1704
DELISTED
SunPower Corporation Common Stock
SPWR
$331K ﹤0.01%
33,760
ENTA icon
1705
Enanta Pharmaceuticals
ENTA
$410M
$331K ﹤0.01%
15,450
LPG icon
1706
Dorian LPG
LPG
$2.36B
$324K ﹤0.01%
+12,650
New +$287K
VTS icon
1707
Vitesse Energy
VTS
$749M
$320K ﹤0.01%
14,287
AVIR icon
1708
Atea Pharmaceuticals
AVIR
$468M
$314K ﹤0.01%
84,030
+15,550
+23% +$58.2K
NAMSW icon
1709
NewAmsterdam Pharma Warrant
NAMSW
$63.8M
$314K ﹤0.01%
150,000
PLRX icon
1710
Pliant Therapeutics
PLRX
$71.8M
$313K ﹤0.01%
+17,300
New +$410K
QNST icon
1711
QuinStreet
QNST
$1.07B
$311K ﹤0.01%
35,170
ACMR icon
1712
ACM Research
ACMR
$5.18B
$309K ﹤0.01%
23,660
TBRG
1713
DELISTED
TruBridge
TBRG
$309K ﹤0.01%
12,530
NFBK
1714
DELISTED
Northfield Bancorp
NFBK
$305K ﹤0.01%
27,750
+6,750
+32% +$72.1K
PNTG icon
1715
Pennant Group
PNTG
$1.33B
$290K ﹤0.01%
23,632
BOOM icon
1716
DMC Global
BOOM
$143M
$289K ﹤0.01%
16,250
VERA icon
1717
Vera Therapeutics
VERA
$2.59B
$286K ﹤0.01%
17,816
BZ icon
1718
Kanzhun
BZ
$7.56B
$282K ﹤0.01%
18,750
TRUP icon
1719
Trupanion
TRUP
$1.22B
$278K ﹤0.01%
14,120
SRRK icon
1720
Scholar Rock
SRRK
$6.74B
$277K ﹤0.01%
36,740
+5,900
+19% +$44.5K
OSUR icon
1721
OraSure Technologies
OSUR
$240M
$276K ﹤0.01%
55,168
MXCT icon
1722
MaxCyte
MXCT
$132M
$268K ﹤0.01%
58,390
TAL icon
1723
TAL Education Group
TAL
$6.88B
$268K ﹤0.01%
44,950
RYTM icon
1724
Rhythm Pharmaceuticals
RYTM
$7.07B
$267K ﹤0.01%
+16,200
New +$292K
GSBC icon
1725
Great Southern Bancorp
GSBC
$874M
$266K ﹤0.01%
5,250
+1,650
+46% +$84.3K

Similar funds

Ensign Peak Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
  • Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
  • Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
  • Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
  • Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
  • Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
  • Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.

Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.